SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹4.94 Cr | ₹-6.68 Cr | ₹1.74 Cr | ₹1.75 Cr | ₹2.38 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHUKRA PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹4.94 Cr |
Mar2022 | ₹-6.68 Cr |
Mar2021 | ₹1.74 Cr |
Mar2020 | ₹1.75 Cr |
Mar2019 | ₹2.38 Cr |
How is Cash Flow from Financing Activities of SHUKRA PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹4.94 Cr | Positive | |
Mar2022 | ₹-6.68 Cr | Negative | |
Mar2021 | ₹1.74 Cr | -0.86 | |
Mar2020 | ₹1.75 Cr | -26.40 | |
Mar2019 | ₹2.38 Cr | - |
Compare Cash Flow from Financing Activities of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹309.4 Cr | 9.8% | -5% | 191.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,649.0 Cr | -0.6% | -3.7% | 66.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,465.0 Cr | 2% | 8.7% | 73% | Stock Analytics | |
CIPLA | ₹125,436.0 Cr | 4.3% | -6.6% | 18.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,321.0 Cr | -2.2% | -5.6% | 17% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,810.0 Cr | 1.2% | -7.3% | 70% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | 9.8% |
-5% |
191.4% |
SENSEX | -0.8% |
-5.8% |
24.5% |
You may also like the below Video Courses